Opening Ceremony & Plenary Session

Join us on October 5, 2020 at 11:00 AM ET for our Opening Ceremony, followed by our first plenary session of the week.

Ribbon Cutting Ceremony

Sponsored by 

Join us for a special “ribbon cutting” featuring talented aerialist, Jamie Holmes. Catch Jamie later in the day at the Patient Pavilion, where she’ll also share her inspiring patient journey with the audience.

State of the Industry

The presentation will cover the many challenges and wins we’ve faced as an industry this year, chief among them being the COVID-19 pandemic and the industry’s remarkable response to this unprecedented global event. On top of facing the challenges of a global crisis, the industry has also taken steps to address critical social issues involving diversity and inclusion during a time when it matters most, a topic near and dear to Scott and the medtech community. 

Scott Whitaker, President and CEO, AdvaMed

Fireside Chat with Dr. Stephen Hahn

Dr. Stephen M. Hahn was sworn in as the 24th Commissioner of Food and Drugs on December 17, 2019. Dr. Hahn is a physician, scientist and health care leader with an extensive background in patient care, academic research and executive leadership. Dr. Hahn will share his experience on the coronavirus task force, strategic priorities for FDA and what’s next for medtech.

Moderator: Scott Whitaker, President and CEO, AdvaMed

Stephen M. Hahn, MD, Commissioner of Food and Drugs, US Food and Drug Administration

Moving Beyond the Case for Diversity: MedTech’s Role in Addressing Health Care Disparities 

Recent events related to the disparate impact of COVID-19 on populations and communities of color, and its connection to underlying health conditions and social determinates of health, have given us all pause. MedTech has a role to play in examining and working to alleviate these disparities starting with an examination of how we can make inroads in creating diversity within the MedTech industry to ensure our technologies benefit all patients. Join us for a fireside discussion of the benefits that diversity brings to our industry and the populations we serve.

Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson

Patrick Hines, MD, PhD, Founder and Chief Executive Officer, Functional Fluidics

Carl St. Bernard, CEO, Board Member, CeloNova Biosciences

Kwame Ulmer, MBA, Principal, Ulmer Ventures